1. Home
  2. ZJYL vs HUMA Comparison

ZJYL vs HUMA Comparison

Compare ZJYL & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

HOLD

Current Price

$2.02

Market Cap

145.9M

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.43

Market Cap

165.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZJYL
HUMA
Founded
2006
2004
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.9M
165.7M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ZJYL
HUMA
Price
$2.02
$0.43
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $1.63
AVG Volume (30 Days)
9.1K
★ 5.6M
Earning Date
08-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 79.37
EPS
★ N/A
N/A
Revenue
N/A
★ $2,038,000.00
Revenue This Year
N/A
$72.32
Revenue Next Year
N/A
$518.79
P/E Ratio
$18.40
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.34
52 Week High
$4.50
$1.90

Technical Indicators

Market Signals
Indicator
ZJYL
HUMA
Relative Strength Index (RSI) 53.41 39.57
Support Level $2.13 N/A
Resistance Level $2.21 $0.75
Average True Range (ATR) 0.12 0.04
MACD 0.03 -0.00
Stochastic Oscillator 82.95 47.09

Price Performance

Historical Comparison
ZJYL
HUMA

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: